Toxicology
Adverse drug events in emergency department patients*,**

Presented in poster form at the Society for Academic Emergency Medicine annual meeting, Chicago, IL, May 1998 (Hafner J Jr, Bucheit K, Squillante M, et al. Adverse drug events in emergency department patients. Acad Emerg Med. 1998;5:528).
https://doi.org/10.1067/mem.2002.121401Get rights and content

Abstract

Study Objective: Adverse drug events (ADEs) have been studied in hospitalized patients. Less is known about this common type of injury in emergency department patients. This study seeks to measure the risks, incidence, severity, and costs of ADEs in an ED population. Methods: ED charts of visits to a university-affiliated tertiary-care ED occurring between March 1 and May 31, 1997, were retrospectively reviewed. The main outcome measures were ADE incidence, severity, and total cost. Visits identified by investigators as containing a suspected ADE were further assessed by using the Naranjo Adverse Drug Reaction (ADR) probability scale. Events judged as probable ADEs (Naranjo ADR probability scale score of >4) were compared with ED control visits best matched by age for disposition, survival, severity, payer, sex, race, age, number of drugs, and total cost. Results: Of 13,602 visits, 13,004 records were available. Three hundred twenty-one had suspected and 217 had probable ADEs (1.7% of evaluable encounters); these were compared with visits by 217 age-matched control patients. Insulin and warfarin were the most commonly responsible drugs. Patients with ADEs were older (mean age 45.1 versus 36.8 years; mean difference 8.3; 95% confidence interval [CI] 3.7 to 12.9), were more often women (odds ratio [OR] 1.48; 95% CI 1.01 to 2.16), took more drugs (mean number of drugs 4.1 versus 1.9; mean difference 2.2; 95% CI 1.7 to 2.8), and were hospitalized more frequently (OR 2.29; 95% CI 1.33 to 3.94) than control patients. Conclusion: ADEs encompassed an important segment of ED encounters and annual health care costs. ED screening may provide useful information about the epidemiology of outpatient ADEs. [Hafner JW Jr, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med. March 2002;39:258-267.]

Introduction

The publication of the Institute of Medicine report on medical errors exposed preventable adverse drug events (ADEs) as an important and previously underrecognized cause of medical injury.1 An ADE is an injury (noxious or harmful effect) resulting from medical intervention related to a drug.2 Studies of the incidence, severity, and cost of ADEs in hospitalized patients have found that between 2.4% and 6.5% of hospitalized patients have an ADE (>770,000 US hospital patients annually), with direct costs between US$1.56 and $4.2 billion annually and an estimated total cost of $12.2 billion in 1996 dollars.2, 3, 4, 5

Although much ADE research thus far has focused on hospital inpatient populations, less is known about emergency department ADEs. Previous reports have noted that ED patients are at high risk for adverse drug interactions (ADIs) and that drug-related illness is not uncommon in the ED.6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 However, the full scope of ADE-related ED visits and the factors that put patients at risk for ADEs remain largely unknown. Inpatient ADEs are most common in the ICU, perhaps because these patients are sicker and require more medications.2, 4, 18, 2018-20 EDs also evaluate many patients with high-severity illnesses who take multiple medications, and we hypothesize that ADEs are also common in this population.

The objective of this study was to measure the incidence of ADEs in an ED population, classify the severity and disposition of ADE visits, quantitate the costs of ADEs in the ED, and identify risk factors for ADEs within an ED population.

Section snippets

Materials and methods

With more than 59,000 annual ED visits and 731 inpatients beds, the study site ED and medical center is the primary teaching hospital for a university medical school and serves as both a primary and tertiary referral center for a surrounding urban and rural population of greater than 2 million persons. Board-certified attending emergency physicians, emergency resident physicians, and rotating off-service resident physicians collaboratively care for a mixed payor population in the ED.

All

Results

During the study period, 13,602 ED visits occurred, with 13,004 (95.6%) ED charts available for review and 321 (2.5% of reviewed ED charts) suspected ADE visits identified. Evaluation of the suspected ADE visit group yielded 217 (1.7% of total reviewed ED charts) visits with a Naranjo ADR probability scale score of greater than 4; these visits were classified as probable ADEs and were compared with control visits. Investigators were highly concordant in assigning Naranjo ADR probability scale

Discussion

ADEs comprise an important proportion of ED visits, ranking higher than common ED diagnoses, such as syncope, pneumonia, and pharyngitis. ADEs usually occurred before ED evaluation, and most patients presented primarily for ADE symptomatology. Few identified ADEs were fatal or life threatening, but most were considered significant. Compared with a control population, patients with ADEs were older, took more medications, and were more frequently hospitalized. ADE visits resulted in a diagnosis

Acknowledgements

Author contributions: SMB and MDS conceived the study and SMB, MDS, and JWH developed its design. JWH and KAB acquired the data. SMB and JWH managed the data, and SMB oversaw quality control. SMB, JWH, and MDS analyzed and interpreted the data and SMB provided statistical advice. JWH drafted the manuscript, and SMB and MDS contributed substantially to its revision. JWH and SMB take responsibility for the paper as a whole.

References (50)

  • EJ Thomas et al.

    Costs of medical injuries in Utah and Colorado

    Inquiry

    (1999)
  • KM Smith et al.

    Drug-related problems in emergency department patients

    Am J Health Syst Pharm

    (1997)
  • MH Beers et al.

    Potential adverse drug interactions in the emergency room. An issue in the quality of care

    Ann Intern Med

    (1990)
  • BS Prince et al.

    Drug-related emergency department visits and hospital admissions

    Am J Hosp Pharm

    (1992)
  • R Raschetti et al.

    Suspected adverse drug events requiring emergency department visits or hospital admissions

    Eur J Clin Pharmacol

    (1999)
  • O Schneitman-McIntire et al.

    Medication misadventures resulting in emergency department visits at an HMO medical center

    Am J Health Syst Pharm

    (1996)
  • CS Stoukides et al.

    Adverse drug reaction surveillance in an emergency room

    Am J Hosp Pharm

    (1993)
  • RR Aparasu

    Drug-related-injury visits to hospital emergency departments

    Am J Health Syst Pharm

    (1998)
  • CE Dennehy et al.

    Drug-related illness in emergency department patients

    Am J Health Syst Pharm

    (1996)
  • DJ Cullen et al.

    Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units

    Crit Care Med

    (1997)
  • DW Bates et al.

    The costs of adverse drug events in hospitalized patients

    JAMA

    (1997)
  • DW Bates et al.

    Incidence and preventability of adverse drug events in hospitalized patients

    J Gen Intern Med

    (1993)
  • CA Naranjo et al.

    A method for estimating the probability of adverse drug reactions

    Clin Pharmacol Ther

    (1981)
  • J Koch-Weser

    Definition and classification of adverse drug reactions

    Drug Information Bull

    (1968)
  • National Coordinating Council for Medication Error Reporting and Prevention

    About medication errors

  • Cited by (0)

    *

    Author contributions are provided at the end of this article.

    **

    Address for reprints: John W. Hafner, Jr., MD, Department of Emergency Medicine, OSF Saint Francis Medical Center, 530 NE, Glen Oak Avenue, Peoria, IL 61637; 309-655-2553, fax 309-655-2602; [email protected];[email protected].

    View full text